Table 2. Clinical information and SARS-CoV RNA in throat wash and saliva from probable SARS case-patients^a.

Patient IDb	Age (y)	Sex	Sampling dayc	Clinical information at sampling day
				Fever	Cough	Dyspnea	Chest x-ray infiltrate	Throat wash (copies/mL)	Saliva (copies/mL)
1	52	M	d2	Yes	Yes	Nod	Yes	1.58 x 105	2.64 x 107
2	28	F	d3	Yes	No	No	Yes	4.69 x 103	1.12 x 105
3	47	F	d3	Yes	No	Nod	Yes	1.56 x 103	1.06 x 105
4	42	M	d3	Yes	No	No	Yes	2.39 x 104	8.22 x 104
5	26	M	d3	Yes	Yes	No	No	3.56 x 103	1.22 x 104
6	32	F	d4	Yes	No	No	Yes	2.88 x 103	7.08 x 103
7	48	M	d4	Yes	Yes	No	Yes	1.32 x 103	9.05 x 104
8	46	M	d4	Yes	No	No	No	3.98 x 103	NA
9	41	F	d4	Yes	No	Nod	No	3.56 x 103	NA
10	47	M	d5	Yes	No	No	Yes	8.10 x 103	9.24 x 104
11	52	M	d5	Yes	No	Yesd	Yes	4.10 x 105	1.74 x 107
12	54	M	d6	Yes	Yes	No	Yes	2.46 x 105	6.38 x 108
13	48	F	d6	Yes	No	No	Yes	2.22 x 103	1.78 x 105
14	26	F	d6	Yes	No	No	Yes	9.73 x 102	9.52 x 103
15	21	F	d7	Yes	Yes	No	No	1.74 x 103	NA
16	28	M	d8	Yes	No	No	Yes	5.93 x 106	4.14 x 107
17	25	F	d9	Yes	No	Yes	Yes	9.58 x 102	2.80 x 104

^aSARS-CoV, severe acute respiratory syndrome–associated coronavirus; M, male; F, female; NA = not available.
^bProbable SARS was diagnosed according to the World Health Organization clinical definitions (15).
^cSampling day 2 (d2) is the second day of fever.
^dIntubation for hypoxia was performed during the course of hospitalization.